Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

AstraZeneca and Daiichi Sankyo’s Enhertu's breakthrough therapy designation as a post-neoadjuvant treatment option for ...

Common symptoms that palliative care teams see in patients with metastatic breast cancer include pain, menopausal symptoms, ...

Clinical trials continue to shape metastatic breast cancer treatment, making therapies safer, more tolerable, and more ...

“Full House” star Dave Coulier, now undergoing treatment for tongue cancer, sat down for an interview with CURE.

Initial support came from in-person groups and survivor stories, providing essential emotional connections and shared experiences. The pandemic shifted support to virtual platforms, which lacked the ...

Enhertu showed improved iDFS over Kadcyla in early-stage HER2-positive breast cancer with residual disease post-neoadjuvant ...

Integrative oncology combines standard cancer treatments with complementary therapies to manage symptoms and improve ...

Dr. Vikram Gorantla explains to CURE that staying healthy and managing side effects helps patients with brain metastases ...

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

Symptoms of stage 3 RCC vary; some patients experience blood in the urine, flank pain, fatigue, weight loss, or a palpable ...

Stage III oral cavity cancer is characterized by larger tumors or lymph node involvement, often diagnosed through physical ...